Cargando…

Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza Virus

The development of effective oncolytic viruses will require understanding the differences in virus replication and killing between normal and cancer cells. Here, we have evaluated infections of metastatic cancer (22Rv1) and benign non-tumorigenic (BPH-1) prostate cell lines with a mutant parainfluen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kedarinath, Kritika, Parks, Griffith D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147676/ https://www.ncbi.nlm.nih.gov/pubmed/35631014 http://dx.doi.org/10.3390/pathogens11050493

Ejemplares similares

DNA methyltransferase inhibitor 5-azacytidine enhances neuroblastoma cell lysis by an oncolytic parainfluenza virus
por: Kedarinath, Kritika, et al.
Publicado: (2023)

Histone Deacetylase Inhibitors Enhance Cell Killing and Block Interferon-Beta Synthesis Elicited by Infection with an Oncolytic Parainfluenza Virus
por: Fox, Candace R., et al.
Publicado: (2019)

Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24
por: Mazar, Joseph, et al.
Publicado: (2018)

Oncolytic parainfluenza virus combines with NK cells to mediate killing of infected and non-infected lung cancer cells within 3D spheroids: role of type I and type III interferon signaling
por: Varudkar, Namita, et al.
Publicado: (2021)

CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cells and Enhances Permissivity to Zika Virus Infection
por: Kedarinath, Kritika, et al.
Publicado: (2022)

Broad-Spectrum, Potent, and Durable Ceria Nanoparticles Inactivate RNA Virus Infectivity by Targeting Virion Surfaces and Disrupting Virus–Receptor Interactions
por: Fox, Candace R., et al.
Publicado: (2023)

The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro
por: Alain, T, et al.
Publicado: (2006)

Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization
por: Li, Yujia, et al.
Publicado: (2018)

Oncolytic herpes simplex virus kills stem-like tumor-initiating colon cancer cells
por: Warner, Susanne G, et al.
Publicado: (2016)

Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells
por: Wang, Lei, et al.
Publicado: (2019)

T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1
por: Harris, Katherine M., et al.
Publicado: (2020)

Features of Circulating Parainfluenza Virus Required for Growth in Human Airway
por: Palermo, Laura M., et al.
Publicado: (2016)

Delivery of a novel membrane-anchored Fc chimera enhances NK cell-mediated killing of tumor cells and persistently virus-infected cells
por: Varudkar, Namita, et al.
Publicado: (2023)

Rhabdomyolysis Associated with Parainfluenza Virus
por: Douvoyiannis, Miltiadis, et al.
Publicado: (2013)

Chemovirotherapeutic Treatment Using Camptothecin Enhances Oncolytic Measles Virus-Mediated Killing of Breast Cancer Cells
por: Tai, Chen-Jei, et al.
Publicado: (2019)

Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition
por: Jennings, Victoria A., et al.
Publicado: (2019)

Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge
por: Clark, Kimberly M., et al.
Publicado: (2011)

Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cells
por: Bofill-De Ros, Xavier, et al.
Publicado: (2015)

Heat-Killed and Live Enterococcus faecalis Attenuates Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia
por: Choi, Young-Jin, et al.
Publicado: (2021)

GZ17-6.02 kills prostate cancer cells in vitro and in vivo
por: Booth, Laurence, et al.
Publicado: (2022)

Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism
por: Bottom-Tanzer, S. F., et al.
Publicado: (2019)

Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability
por: Leja, Justyna, et al.
Publicado: (2010)

Oncolytic virus efficiency inhibited growth of tumour cells with multiple drug resistant phenotype in vivo and in vitro
por: Goncharova, Elena P., et al.
Publicado: (2016)

Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells
por: Kilinc, Mehmet Okyay, et al.
Publicado: (2016)

Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells
por: Al-Ziaydi, Ahmed Ghdhban, et al.
Publicado: (2020)

Optimizing environmental safety and cell-killing potential of oncolytic Newcastle Disease virus with modifications of the V, F and HN genes
por: de Graaf, J. Fréderique, et al.
Publicado: (2022)

Enhanced growth of influenza A virus by coinfection with human parainfluenza virus type 2
por: Goto, Hideo, et al.
Publicado: (2015)

Characterization of Two Porcine Parainfluenza Virus 1 Isolates and Human Parainfluenza Virus 1 Infection in Weaned Nursery Pigs
por: Welch, Michael, et al.
Publicado: (2022)

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
por: Ghose, Jayeeta, et al.
Publicado: (2021)

Seasonality and clinical impact of human parainfluenza viruses
por: Maykowski, Philip, et al.
Publicado: (2018)

Bluetongue Viruses Act as Novel Oncolytic Viruses to Effectively Inhibit Human Renal Cancer Cell Growth In Vitro and In Vivo
por: Wang, Haozhou, et al.
Publicado: (2021)

Erratum to: Oncolytic virus efficiency inhibited growth of tumour cells with multiple drug resistant phenotype in vivo and in vitro
por: Goncharova, Elena P., et al.
Publicado: (2016)

Evaluating a Parainfluenza Virus 5-Based Vaccine in a Host with Pre-Existing Immunity against Parainfluenza Virus 5
por: Chen, Zhenhai, et al.
Publicado: (2012)

Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate
por: Dueregger, Andrea, et al.
Publicado: (2015)

Genome Sequence of the Parainfluenza Virus 5 Strain That Persistently Infects AGS Cells
por: Wignall-Fleming, Elizabeth, et al.
Publicado: (2016)

MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small cell lung cancer cells
por: Li, Jhy-Ming, et al.
Publicado: (2013)

A vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growth
por: Yoon, A-Rum, et al.
Publicado: (2015)

The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization
por: Zhou, Heng, et al.
Publicado: (2015)

Two Cases of Primary Human Parainfluenza Virus 1 Pneumonia in Which Bronchoalveolar Lavage Fluid Yielded Human Parainfluenza Virus 1
por: Ishiguro, Takashi, et al.
Publicado: (2019)

Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing
por: Inoue, Tomoyoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g2i1pu9irihe5rru0o5p7gjite